1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "145915-58-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-103442


    EGFR Amyloid-β Cancer Neurological Disease
    CGP52411 (DAPH) is a high selective, potent, orally active and ATP-competitive EGFR inhibitor with an IC50 of 0.3 μM. CGP52411 blocks the toxic influx of Ca 2+ ions into neuronal cells, and dramatic inhibits and reverses the formation of β-amyloid (Aβ42) fibril aggregates associated with Alzheimer's disease.